- Home
- JWN vs IOVA Comparison
JWN vs IOVA Comparison
Compare JWN & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWN
- IOVA
- Stock Information
- Founded
- JWN 1901
- IOVA 2007
- Country
- JWN United States
- IOVA United States
- Employees
- JWN N/A
- IOVA N/A
- Industry
- JWN Clothing/Shoe/Accessory Stores
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JWN Consumer Discretionary
- IOVA Health Care
- Exchange
- JWN Nasdaq
- IOVA Nasdaq
- Market Cap
- JWN 3.8B
- IOVA 3.6B
- IPO Year
- JWN N/A
- IOVA N/A
- Fundamental
- Price
- JWN $22.90
- IOVA $10.07
- Analyst Decision
- JWN Hold
- IOVA Strong Buy
- Analyst Count
- JWN 14
- IOVA 10
- Target Price
- JWN $20.07
- IOVA $24.80
- AVG Volume (30 Days)
- JWN 3.2M
- IOVA 6.1M
- Earning Date
- JWN 08-27-2024
- IOVA 11-05-2024
- Dividend Yield
- JWN 3.39%
- IOVA N/A
- EPS Growth
- JWN 804.21
- IOVA N/A
- EPS
- JWN 1.70
- IOVA N/A
- Revenue
- JWN $14,969,000,000.00
- IOVA $32,772,000.00
- Revenue This Year
- JWN $1.95
- IOVA $13,836.92
- Revenue Next Year
- JWN $1.87
- IOVA $183.20
- P/E Ratio
- JWN $13.16
- IOVA N/A
- Revenue Growth
- JWN 1.02
- IOVA 13669.75
- 52 Week Low
- JWN $12.88
- IOVA $3.21
- 52 Week High
- JWN $24.03
- IOVA $18.33
- Technical
- Relative Strength Index (RSI)
- JWN 58.89
- IOVA 44.01
- Support Level
- JWN $21.55
- IOVA $8.80
- Resistance Level
- JWN $23.58
- IOVA $11.80
- Average True Range (ATR)
- JWN 0.73
- IOVA 0.61
- MACD
- JWN 0.06
- IOVA -0.29
- Stochastic Oscillator
- JWN 81.20
- IOVA 24.39
About JWN Nordstrom Inc.
Nordstrom is a fashion retailer that operates about 93 department stores and approximately 260 off-price Nordstrom Rack stores. The company also operates both full- and off-price e-commerce sites, two clearance stores, and seven Local locations. Nordstrom's largest merchandise categories are women's apparel (27% of 2023 sales), shoes (26% of 2023 sales), men's apparel (15% of 2023 sales), and beauty (13% of 2023 sales). Nordstrom, which traces its history to a shoe store opened in Seattle in 1901, continues to be partially owned and managed by members of the eponymous family.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.